In our previous study, we have concluded that administration of PI can prevent Alzheimer's disease, increase hippocampal neurogenesis, decrease microglial population, and decrease the expression of Tau and pTau after single or repeated administration (Kim et al., 2019). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.